ContextVision AB (publ) (OSL:CONTX)

Market Cap	246.32M -49.5%
Revenue (ttm)	115.15M -19.8%
Net Income	3.82M -83.4%
EPS	0.05 -83.2%
Shares Out	75.10M
PE Ratio	65.61
Forward PE	44.15
Dividend	n/a
Ex-Dividend Date	n/a

Volume	58,825
Average Volume	112,781
Open	3.150
Previous Close	3.150
Day's Range	3.150 - 3.280
52-Week Range	2.700 - 6.350
Beta	0.39
RSI	51.10
Earnings Date	Feb 19, 2026

About ContextVision AB

ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally. The company offers image quality solutions for ultrasound, as well as its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image quality of 3D ultrasound; and Rivent Mobile, a 2D image enhancement for handheld devices for diagnostics in various fields, including radiology, cardio...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1989
• Employees: 44
• Stock Exchange: Oslo Børs
• Ticker Symbol: CONTX

Financial Performance

In 2024, ContextVision AB's revenue was 130.84 million, a decrease of -1.33% compared to the previous year's 132.60 million. Earnings were 24.68 million, a decrease of -24.60%.

Financial numbers in SEK